Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 26, 2024NeurologyOpen Access

Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

Peter J. GoadsbyPeter J. GoadsbyKing's College LondonDFDeborah I. FriedmanTexas NeurologyDHDagny Holle-LeeWest German Heart and Vascular Center Essen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Goadsby et al. (2024) studied this question.

synapsesocial.com/papers/68e6327cb6db6435875c4170https://doi.org/10.1212/wnl.0000000000209584
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition2018 · 10,900 citations
  2. 2Patient-Centered Treatment of Chronic Migraine With Medication Overuse2022 · 72 citations
  3. 3Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache2021 · 44 citations
  4. 4Probable medication-overuse headache: The effect of a 2-month drug-free period2007 · 140 citations